Pegoraro C, Bondovalli C, Dall'Oglio B, Schiavon L, Luciano M, Parma A
Divisione di Urologia, Azienda Ospedaliera Carlo Poma, Mantova.
Arch Ital Urol Androl. 1996 Feb;68(1):35-8.
We have evaluated 79 patients affected by bladder cancer T1G3: 31 underwent just endoscopy, 11 radiotherapy, 10 cystectomy and 27 topical chemotherapy. At five years 44 patients were alive and disease free, 7 were alive but recurrent in TA, 3 were alive but in metastatic progression, 17 were died because of the tumor, 3 died because of the therapy, and 5 died disease free. The authors believe that this patients could be treated with BCG as first treatment choice performing cystectomy when relapse or progression occuring.
我们评估了79例T1G3期膀胱癌患者:31例仅接受了内镜检查,11例接受了放疗,10例接受了膀胱切除术,27例接受了局部化疗。五年时,44例患者存活且无疾病,7例存活但TA期复发,3例存活但处于转移进展期,17例因肿瘤死亡,3例因治疗死亡,5例无疾病死亡。作者认为,这些患者可将卡介苗作为首选治疗方法,复发或进展时行膀胱切除术。